GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Korea Arlico Pharm Co Ltd (XKRX:260660) » Definitions » Market Cap

Korea Arlico Pharm Co (XKRX:260660) Market Cap : ₩51,046 Mil (As of Dec. 13, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Korea Arlico Pharm Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Korea Arlico Pharm Co's share price for the quarter that ended in Sep. 2024 was ₩4065. Korea Arlico Pharm Co's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 15 Mil. Therefore, Korea Arlico Pharm Co's market cap for the quarter that ended in Sep. 2024 was ₩61,029 Mil.

Korea Arlico Pharm Co's quarterly market cap declined from Mar. 2024 (₩80,021 Mil) to Jun. 2024 (₩72,064 Mil) and declined from Jun. 2024 (₩72,064 Mil) to Sep. 2024 (₩61,029 Mil).

Korea Arlico Pharm Co's annual market cap declined from Dec. 2021 (₩115,303 Mil) to Dec. 2022 (₩98,338 Mil) and declined from Dec. 2022 (₩98,338 Mil) to Dec. 2023 (₩85,576 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Korea Arlico Pharm Co's Enterprise Value for Today is ₩81,836 Mil.


Korea Arlico Pharm Co Market Cap Historical Data

The historical data trend for Korea Arlico Pharm Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Korea Arlico Pharm Co Market Cap Chart

Korea Arlico Pharm Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only 135,128.12 132,627.55 115,302.91 98,337.77 85,576.38

Korea Arlico Pharm Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 90,530.80 85,576.38 80,021.42 72,064.32 61,029.47

Competitive Comparison of Korea Arlico Pharm Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Korea Arlico Pharm Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Korea Arlico Pharm Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Korea Arlico Pharm Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Korea Arlico Pharm Co's Market Cap falls into.



Korea Arlico Pharm Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Korea Arlico Pharm Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=₩5700*15.0134
=₩85,576

Korea Arlico Pharm Co's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=₩4065*15.0134
=₩61,029

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Korea Arlico Pharm Co  (XKRX:260660) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Korea Arlico Pharm Co Market Cap Related Terms

Thank you for viewing the detailed overview of Korea Arlico Pharm Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Korea Arlico Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
7-21, Baumoe-ro 27-gil, Seocho-gu, Seoul, KOR
Korea Arlico Pharm Co Ltd is engaged in the business of manufacturing and selling pharmaceuticals products. The company offers products in the area of the circulatory system, antiplatelet, muscle relaxants, diabetes, antibiotic and chemotherapy, allergy and respiratory disease, ointment, vitamin and health supplements, digestive system, and metabolic disease. It provides products in various forms such as tablets, capsules, gel, and cream.

Korea Arlico Pharm Co Headlines

No Headlines